CS
ACHV icon

Credit Suisse’s Achieve Life Sciences ACHV Stock Holding History

Credit Suisse’s Portfolio ACHV Stock Details ACHV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-14
Closed -$83K – 4567
2014
Q3 		$83K Sell
14
-4
-22% -$27.8K ﹤0.01% 4316
2014
Q2 		$150K Buy
18
+4
+29% +$49.1K ﹤0.01% 4455
2014
Q1 		$352K Hold
14
– – ﹤0.01% 3974
2013
Q4 		$248K Buy
14
+9
+180% +$158K ﹤0.01% 4203
2013
Q3 		$101K Hold
5
– – ﹤0.01% 4106
2013
Q2 		$110K Buy
+5
New +$112K ﹤0.01% 4000

Other funds holding ACHV

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Credit Suisse's ACHV Position: Q4 2014 in Review

Credit Suisse sold out of Achieve Life Sciences (ACHV) in Q4 2014, closing a stake of 14 shares — an estimated $83K sold.

Credit Suisse first reported a position in ACHV in Q2 2013 and held it in 6 quarters. The position peaked at $352K in Q1 2014. 56 funds tracked by Wall St. Rank hold ACHV as of Q4 2014.

  • Credit Suisse reported no remaining Achieve Life Sciences position as of Q4 2014 after selling out during the quarter.
  • Credit Suisse sold 14 Achieve Life Sciences shares in Q4 2014, an estimated $83K.
  • Credit Suisse first reported a position in Achieve Life Sciences in Q2 2013 and held it in 6 quarters.
  • Credit Suisse's Achieve Life Sciences position peaked at $352K in Q1 2014.
  • 56 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q4 2014.

Based on Credit Suisse's 13F filing for Q4 2014, filed 13 Feb 2015.